orforglipron vs oral semaglutide A new class of GLP-1 that works differently than oral just got one step closer to FDA approval. Eli Lilly released new Phase 3 data on orforglipron. Swipe to learn GLP-1 Pill Orforglipron More Effective

Providers must submit clinical documentation justifying the need for the prescribed medication and address any additional inquiries regarding previous treatments, contraindications, and specific conditions related to the medication class

Key Takeaways Stomach pain on GLP-1s is common and usually temporary Slower digestion is the main cause Smaller meals and hydration make a significant difference High-fat foods can worsen symptoms Dose timing and gradual increases help your body adjust Proper medication storage supports consistent results

No score below 6.5, which is the threshold Finnrick uses for a confident rating

But we're not flying blind